Paul Katz, DO
Family Medicine · Cecilton, MDNPI 1629047154
Payments from drug & device makers
Across 43 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orexo US, Inc.$162
- Indivior Inc.$93
- Lilly USA, LLC$91
- AstraZeneca$67
- Novo Nordisk$64
- Otsuka Pharmaceutical Development & Commercialization, Inc.$48
- plus $229 from 8 others
What the payments were for
- Food & beverage$753100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orexo US, Inc. | 11 | $162 |
| Indivior Inc. | 5 | $93 |
| Lilly USA, LLC | 5 | $91 |
| AstraZeneca | 4 | $67 |
| Novo Nordisk | 3 | $64 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $48 |
| AbbVie | 2 | $36 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Braeburn Inc. | 2 | $33 |
| Medtronic | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Linus Health, Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
How this compares
$753 in reported general payments places this provider in the 60th percentile of 1,193 family medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 23 | $24,778 |
| XareltoRivaroxaban | 14 | $18,222 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 20 | $4,138 |
| Levothyroxine Sodium | 51 | $2,020 |
| Atorvastatin Calcium | 170 | $1,825 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,763 |
| Tamsulosin Hcl | 71 | $1,657 |
| Metoprolol Succinate | 69 | $1,134 |
| Celecoxib | 13 | $1,117 |
| Pregabalin | 52 | $872 |
| Esomeprazole Magnesium | 11 | $842 |
| Gabapentin | 51 | $796 |
| Lisinopril | 92 | $685 |
| Losartan Potassium | 67 | $652 |
| Pravastatin Sodium | 15 | $592 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Cecilton
- Stephen OngOxon Hill$5.9M
- Stephan BartWoodstock$1.7M
- Karen DonaldsonBaltimore$899K
- Rajiv DuaColumbia$765K
- Greg TampusLutherville Timonium$735K
- Louis JacquesBaltimore$522K
- Stephanie MellerOxon Hill$518K
- Sharon ChungGlen Burnie$333K
- Michael ObiefuneBaltimore$291K
- Thomas LawrenceBerlin$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.